| 000 | 01380 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250512005822.0 | ||
| 264 | 0 | _c19891020 | |
| 008 | 198910s 0 0 eng d | ||
| 022 | _a0002-953X | ||
| 024 | 7 |
_a10.1176/ajp.146.10.1251 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBaraban, J M | |
| 245 | 0 | 0 |
_aSecond messenger systems and psychoactive drug action: focus on the phosphoinositide system and lithium. _h[electronic resource] |
| 260 |
_bThe American journal of psychiatry _cOct 1989 |
||
| 300 |
_a1251-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLithium _xpharmacology |
| 650 | 0 | 4 | _aModels, Chemical |
| 650 | 0 | 4 |
_aNeurotransmitter Agents _xmetabolism |
| 650 | 0 | 4 |
_aPhosphatidylinositols _xmetabolism |
| 650 | 0 | 4 |
_aPsychotropic Drugs _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xdrug effects |
| 650 | 0 | 4 | _aReceptors, Cytoplasmic and Nuclear |
| 650 | 0 | 4 |
_aSecond Messenger Systems _xdrug effects |
| 700 | 1 | _aWorley, P F | |
| 700 | 1 | _aSnyder, S H | |
| 773 | 0 |
_tThe American journal of psychiatry _gvol. 146 _gno. 10 _gp. 1251-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1176/ajp.146.10.1251 _zAvailable from publisher's website |
| 999 |
_c2577247 _d2577247 |
||